Medicare Enrolled

Dr. Christopher Kwoh, M.D.

Nephrology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1700 ROMANO PARK LN, Houston, TX 77090
2818669995
Registered in NPPES since 2006
NPI: 1962427534 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kwoh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kwoh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kwoh

Dr. Christopher Kwoh is a nephrology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kwoh performed 1,852 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kwoh received a total of $408,696 from 46 pharmaceutical and/or device companies across 1080 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kwoh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 28% volume in TX $408,696 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,852
Medicare services
Top 28% in TX for nephrology
Not available
Unique patients (not deduplicated)
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
596 $52 $182
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
370 $58 $256
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
228 $275 $706
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
219 $64 $160
Home dialysis services per month
Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older.
175 $200 $586
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
94 $121 $336
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
69 $229 $588
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
37 $134 $348
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
31 $83 $226
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
18 $40 $100
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
15 $100 $262
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$408,696
Total received (2018-2024)
Avg $58,385/year across 7 years
Top 1% in TX for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,080
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$142,870
2023
$66,596
2022
$87,401
2021
$79,520
2020
$11,011
2019
$6,258
2018
$15,040

Payments by company (2024)

Bayer Healthcare Pharmaceuticals Inc.
$66,934
Otsuka America Pharmaceutical, Inc.
$65,218
Fresenius USA Marketing, Inc.
$6,142
CSL Behring
$1,796
AstraZeneca Pharmaceuticals LP
$953
Travere Therapeutics, Inc.
$328
Boehringer Ingelheim Pharmaceuticals, Inc.
$195
AKEBIA THERAPEUTICS INC
$190
Novartis Pharmaceuticals Corporation
$189
Amgen Inc.
$184
Otsuka Pharmaceutical Development & Commercialization, Inc.
$112
Novo Nordisk Inc
$105
Mallinckrodt Hospital Products Inc.
$104
Ardelyx, Inc.
$99
Aurinia Pharma U.S., Inc.
$83
Lilly USA, LLC
$68
CALLIDITAS THERAPEUTICS US INC.
$51
Vifor Pharma, Inc.
$50
GlaxoSmithKline, LLC.
$45
Kyowa Kirin, Inc.
$22
Top 3 companies account for 96.8% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$166,136
Bayer Healthcare Pharmaceuticals Inc.
$116,292
Bayer HealthCare Pharmaceuticals Inc.
$84,649
Fresenius USA Marketing, Inc.
$18,170
OPKO Pharmaceuticals, LLC
$7,836
AstraZeneca Pharmaceuticals LP
$2,341
AKEBIA THERAPEUTICS INC
$2,203
CSL Behring
$1,796
Relypsa, Inc.
$1,108
NxStage Medical, Inc.
$1,050
Mallinckrodt Hospital Products Inc.
$877
Horizon Therapeutics plc
$614
Novartis Pharmaceuticals Corporation
$611
Travere Therapeutics, Inc.
$478
GlaxoSmithKline, LLC.
$428
Amgen Inc.
$373
Shire North American Group Inc
$356
Vifor Pharma, Inc.
$335
Keryx Biopharmaceuticals, Inc.
$277
Aurinia Pharma U.S., Inc.
$241
Mallinckrodt Enterprises LLC
$226
Boehringer Ingelheim Pharmaceuticals, Inc.
$209
Mallinckrodt LLC
$194
Takeda Pharmaceuticals U.S.A., Inc.
$183
Calliditas Therapeutics US Inc.
$179
Shionogi Inc
$141
CALLIDITAS THERAPEUTICS US INC.
$140
Lilly USA, LLC
$116
Otsuka Pharmaceutical Development & Commercialization, Inc.
$112
Novo Nordisk Inc
$105
Exeltis, USA Inc.
$102
Ardelyx, Inc.
$99
Horizon Pharma plc
$89
Mauna Kea Technologies, Inc.
$89
Daiichi Sankyo Inc.
$80
ANI Pharmaceuticals, Inc.
$70
GENZYME CORPORATION
$64
Amarin Pharma Inc.
$63
Alnylam Pharmaceuticals Inc.
$51
Kyowa Kirin, Inc.
$47
Ultragenyx Pharmaceutical Inc.
$41
Retrophin, Inc.
$38
Medtronic, Inc.
$36
West-Ward Pharmaceuticals
$21
Boston Scientific Corporation
$16
Arbor Pharmaceuticals, Inc.
$16
Top 3 companies account for 89.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 2008 Machines · ACTHAR · AURYXIA · Auryxia · BENLYSTA · Critline - Monitors · Crysvita · Dialyzers · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · Edarbi · FABRAZYME · FARXIGA · Fabhalta · Fetroja · GATTEX · GENERAL VASCULAR INTERVENTION · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · MOUNJARO · Mitigare · NO_PRODUCT · NXSTAGE SYSTEM ONE · Not Product Related · OXLUMO · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · RAYOS · Rayaldee · Rayaldee (old) · Rivfloza · Rybelsus · SAMSCA · TARPEYO · TOLVAPTAN · Tavneos · Uloric · Vafseo · Vascepa · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nephrology specialist in Houston?
Compare nephrologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists in nearby ZIP areas
170
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE NORTHWEST
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kwoh is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kwoh experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kwoh performed 596 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kwoh receive payments from pharmaceutical companies?
Yes. Dr. Kwoh received a total of $408,696 from 46 companies across 1,080 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kwoh's costs compare to other nephrologists in Houston?
Dr. Kwoh's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kwoh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →